Entero Healthcare Solutions' Q3 FY 2025-26 Quarterly Results
- 13 Feb 2026
Result Summary
- Entero Healthcare Solutions Ltd reported a 8.6% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 25.2%.
- Its expenses for the quarter were up by 8.6% QoQ and 25.3% YoY.
- The net profit decreased 7.5% QoQ and increased 15.0% YoY.
- The earnings per share (EPS) of Entero Healthcare Solutions Ltd stood at 6.34 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 1711.13 | 1575.74 | 1366.49 | 8.6% | 25.2% |
Total Expenses | 1662.55 | 1531.11 | 1327.05 | 8.6% | 25.3% |
Profit Before Tax | 40.40 | 44.62 | 39.44 | -9.5% | 2.4% |
Tax | 6.52 | 8.02 | 9.99 | -18.7% | -34.7% |
Profit After Tax | 33.87 | 36.60 | 29.45 | -7.5% | 15.0% |
Earnings Per Share | 6.34 | 7.25 | 5.84 | -12.6% | 8.6% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Entero Healthcare Solutions Ltd operates within the healthcare industry, primarily focusing on the distribution and supply of pharmaceutical products. The company is known for its comprehensive portfolio of healthcare solutions, ranging from generic drugs to specialized medications and related healthcare services. As of the latest available data, no recent major developments or changes in strategy have been noted, but the company continues to serve a wide range of healthcare providers and institutions. Entero Healthcare Solutions Ltd remains a key player in the Indian healthcare sector, leveraging its extensive network and expertise in pharmaceutical logistics to maintain its market presence.
Revenue
In the third quarter of the fiscal year 2026, Entero Healthcare Solutions Ltd reported a total income of ₹1,711.13 crores. This represents an 8.6% increase compared to the previous quarter's income of ₹1,575.74 crores. Year-over-year, the total income increased by 25.2% from ₹1,366.49 crores in Q3FY25. These figures highlight the company's revenue growth over both the quarter and year. The consistent increase in total income suggests a robust demand for the company's products and services, reflecting its strong market position and operational efficiency in revenue generation.
Profitability
For Q3FY26, the company's Profit Before Tax (PBT) was ₹40.40 crores, reflecting a decrease of 9.5% compared to the previous quarter (Q2FY26) which was ₹44.62 crores. However, on a year-over-year basis, there was a slight increase of 2.4% from ₹39.44 crores in Q3FY25. The Profit After Tax (PAT) for Q3FY26 stood at ₹33.87 crores, marking a decline of 7.5% from Q2FY26's ₹36.60 crores, but an increase of 15.0% year-over-year from ₹29.45 crores in Q3FY25. The company's Earnings Per Share (EPS) also showed a decrease, standing at ₹6.34 compared to ₹7.25 in Q2FY26, but showed growth from ₹5.84 in Q3FY25. These figures indicate a mixed performance in profitability metrics over different periods.
Operating Metrics
Total expenses for Entero Healthcare Solutions Ltd in Q3FY26 were ₹1,662.55 crores, an 8.6% increase from Q2FY26's ₹1,531.11 crores, and a 25.3% rise from ₹1,327.05 crores in Q3FY25. The tax expense for the quarter was ₹6.52 crores, which decreased by 18.7% quarter-over-quarter and 34.7% year-over-year. This decrease in tax expenses could be attributed to changes in the company's tax strategies or variations in applicable tax rates. The consistent increase in total expenses suggests that the company is managing a significant scale of operations, which aligns with the growth in revenue. However, the decrease in tax expense has contributed to the overall financial management of the company.